Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 247-252

  Uchida, Naomi ^a   Kasai, Hisanori ^a   Takeda, Yukihiro ^a   Maekawa, Ryuji ^a   Sugita, Kenji ^a   Yoshioka, Takayuki ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Cisplatin; Combination chemotherapy; Etoposide; Nedaplatin

Indexed keywords

CISPLATIN; ETOPOSIDE; NEDAPLATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHT; CARCINOMA, LEWIS LUNG; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ETOPOSIDE; FEMALE; HEMATOPOIESIS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, NUDE; ORGANOPLATINUM COMPOUNDS; SURVIVAL ANALYSIS;

EID: 0031898588     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Totani T, Aono K, Komura M and Adachi Y: Synthesis of (glycolato-O, O') diammineplatinum (II) and its related complexes. Chem Lett 429-432,1986.
2. Suzumura S, Kato T, Ueda R and Ohta K: Effect of treatment schedule on antitumor activity of glycolato-O, O' diammineplatinum (II), a new platinum derivatives: Comparison with cis-diamminedichloroplatinum (II). Anticancer Res 9: 1083-1088, 1989.
3. Shiratori O, Kasai H, Uchida N, Takeda Y, Totani T and Sato K: anti-tumor activity of 254-S, a platinum complex, in rodents. In: Ishigami J, (ed). Recent advances in Chemotherapy. University of Tokyo Press, 635-636, 1985.
4. Koenuma M, Kasai H, Uchida N, Wada T, Hattori M, Oguma T, Totani T and Inaba M: Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammine glycolatoplatinllm (254-S) and cis-diamnline dichloroplatinum. Anticancer Res 15: 417-422, 1995.
5. Kameyama Y, Okazaki N, Nakagawa M, Koshida H, Nakamura M and Gemba M: Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices. Toxicol Lett 52: 15-24, 1990.
6. Furuse K, Fukuoka M, Ohshima S, Ariyoshi Y, Fujii M, Kurita Y, Hasegawa K, Homma T, Tamura M, Inoue S, Nishiwaki Y, Kimura I and Niitani H: Phase II clinical study of (glycolato-O, O') diammineplatinum (II), a new platinum complex, for primary lung cancer. Proc Am Soc Clin Oncol 8: 238, 1989.
7. Fukuda M, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Hara K and Saijo N: Phase II study of (glycolato-O, O') diammineplatinum (II), a novel platinum complex, in the treatment of non-small-cell lung cancer. Cancer Chemother Pharmacol 26: 393-396, 1990.
8. Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S and Ohta K: An early phase II study of cis-diammine glycolato platinum, 254-S, for head and neck cancers. Jpn J Cancer Chemother 19: 863-869, 1992.
9. Akaza H, Togashi M, Nishio Y, Miki T, Kotake T, Matumura Y, Yoshida O and Aso Y: Phase II study of cis-diammine (glycolato) platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. Cancer Chemother Pharmacol 31: 187-192, 1992.
10. Kato T, Noda K, Hirabayashi K and Nishimura H: Phase II study of cis-diammine (glycolato) platinum [254-S), a new platinum complex, for gynecological malignancy. Proc 16th Intl Cong Chemother, Anticancer section 823: 1-2, 1989.
11. Mable JA: Therapeutic synergjsm in murine tumors for combinations of cis-diamminedichloroplatinum with VP16-213 or BCNU. Proc Am Assoc Cancer Res and Am Assoc Clin Oncol 20: 230, 1979.
12. Longeval E and Klastersky J: Combination chemotherapy with cisplatin and etoposide in brouchogenic squamous cell and adenocarcinoma. a Study of the EORTC Lung Cancer Working Party (Belguim). Cancer 50: 2751-2756, 1982.
13. Evance WK, Osoba D, Feld R, Shepherd FA, Bazos MJ and DeBoer G: Etoposide (VP-16) and Cisplatin: an effective treatment for relapse in small cell lung cancer. J Clin Oncol 3: 65-71, 1985.
14. Klastersky J, Sculier JP, Lacroix H: A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 8: 1556-1562, 1990.
15. Ekimoto H, Aikawa M, Takahashi K and Mastuda A: Fundamental Studies on combination chemotherapy of Cisplatin with peplomycin against human squamous cell carcinomas in nude mice. Jpn J Cancer Chemother 12: 70-76, 1985.
16. Berenbaum MC: Criteria for analyzing interactions between biologically active agents. Adv in Cancer Res 35: 269-335, 1981.
17. Joss RA, Cavalli F, Goldhirsch a, Mermillod B and Bruner KW: New agents in non-small cell lung cancer. Cancer Treat Rev 11: 205-236, 1984.
18. Fujita J, Saijo N, Eguchi K, Shimizu E, Shinkai T, Tominaga K, Sasaki Y, Futami H, Sakurai M and Hoshi A: Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer. Jpn J Cancer Res 76: 420-423, 1985.
19. Uchida T, Okamoto K, Nishikawa K and Takahashi K: Combination of Etoposide with Ciaplatin or Cyclophosphamide in the treatment of mouse Lewis lung carcimoma. Jpn J Cancer Chemother 13: 75-79, 1986.